Definitive Healthcare Corp. (DH) stock plummeted by 9.6% in Monday's intraday trading session, following a price target cut by analysts at Deutsche Bank.
According to a research note from Deutsche Bank, the bank lowered its price target on Definitive Healthcare shares from $5 to $4, while maintaining a "Hold" rating on the stock.
The price target reduction reflects analysts' concerns about the company's prospects and future performance, which contributed to the sharp sell-off in Definitive Healthcare's stock price on Monday.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。